相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease
X. Wang et al.
DIABETES & METABOLISM (2020)
The Contribution of the Adipose Tissue-Liver Axis in Pediatric Patients with Nonalcoholic Fatty Liver Disease after Laparoscopic Sleeve Gastrectomy
Antonio Franchitto et al.
JOURNAL OF PEDIATRICS (2020)
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
Jan Best et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC
Svenja Sydor et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2020)
Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels
Ahmed Abdallah Salman et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease
Ali Canbay et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift
Christopher J. Nolan et al.
DIABETES & VASCULAR DISEASE RESEARCH (2019)
On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity
Oleg Kovrov et al.
JOURNAL OF LIPID RESEARCH (2019)
Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective
Ali Canbay et al.
PLOS ONE (2019)
Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation
Ghada Abdelmoemen et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2019)
Association Between Visfatin and Hepatic Steatosis in the General Population During Long-Term Follow-Up
Katharina Johannsen et al.
HORMONE AND METABOLIC RESEARCH (2019)
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
Simona Marchisello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Characterization of Vitamin A Metabolome in Human Livers With and Without Nonalcoholic Fatty Liver Disease
Guo Zhong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Hepatic Gene Expression Profiles Differentiate Steatotic and Non-steatotic Grafts in Liver Transplant Recipients
Ondrej Seda et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Prognostic Role of Apelin Receptor Expression in Hepatocellular Carcinoma Treated With Curative Surgical Resection
Taebum Lee et al.
ANTICANCER RESEARCH (2019)
Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells
Ying Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
Total adiponectin in overweight and obese subjects and its response to visceral fat loss
Salah Gariballa et al.
BMC ENDOCRINE DISORDERS (2019)
Metabolic Syndrome in Heart Failure: Friend or Foe?
Michele Arcopinto et al.
HEART FAILURE CLINICS (2019)
Insulin Resistance in Children
Veronica Maria Tagi et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children?
Marta Flisiak-Jackiewicz et al.
ADVANCES IN MEDICAL SCIENCES (2019)
Plasma concentration and expression of adipokines in epicardial and subcutaneous adipose tissue are associated with impaired left ventricular filling pattern
Kacper Toczylowski et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?
Amedeo Lonardo et al.
ACTA DIABETOLOGICA (2019)
Leptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later?
Andrea G. Izquierdo et al.
NUTRIENTS (2019)
Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes
Eun Shil Hong et al.
BMJ OPEN DIABETES RESEARCH & CARE (2019)
The association between dietary antioxidants and adipokines level among obese women
Elnaz Daneshzad et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target
Huarong Chen et al.
THERANOSTICS (2019)
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
Na Jiao et al.
GUT (2018)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
Ali Saeed et al.
NUTRIENTS (2018)
The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans
Andreas Peter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)
Clinical Significance of Serum Adiponectin and Resistin Levels in Liver Cirrhosis
Telma Erotides da Silva et al.
ANNALS OF HEPATOLOGY (2018)
Human plasma retinol-binding protein (RBP4) is also a fatty acid-binding protein
Massimiliano Perduca et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2018)
Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis
Ji-nian Wang et al.
GENE (2018)
Hepatocellular Carcinoma-Associated Protein TD26 Interacts and Enhances Sterol Regulatory Element-Binding Protein 1 Activity to Promote Tumor Cell Proliferation and Growth
Chenchen Wang et al.
HEPATOLOGY (2018)
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
Carmine Carbone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Relationship Between 12 Adipocytokines and Distinct Components of the Metabolic Syndrome
Thomas Ebert et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Exploring new treatment paradigms for alcoholic hepatitis by extrapolating from NASH and cholestasis
Thoetchai (Bee) Peeraphatdit et al.
JOURNAL OF HEPATOLOGY (2018)
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A. Harrison et al.
LANCET (2018)
Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle
Tae Woo Jung et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis
Paul Horn et al.
SCIENTIFIC REPORTS (2018)
Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation
Anna Cinkajzlova et al.
NUTRITION & DIABETES (2018)
Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases
Jonathan G. Stine et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Adiponectin Signaling Pathways in Liver Diseases
Tania Gamberi et al.
BIOMEDICINES (2018)
Unsaturated Fatty Acids Increase the Expression of Hepassocin through a Signal Transducer and Activator of Transcription 3-Dependent Pathway in HepG2 Cells
Kai-Pi Cheng et al.
LIPIDS (2018)
Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis
Katharina Brandl et al.
JOURNAL OF HEPATOLOGY (2018)
Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis
Rebekka Pohl et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2017)
Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection
Takefumi Kimura et al.
HEPATOLOGY RESEARCH (2017)
Deletion of HNF1α in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice
Qi Ni et al.
FEBS LETTERS (2017)
The Correlation Between Circulating Betatrophin and Insulin Resistance in General Population: A Meta-Analysis
Jinling Xu et al.
HORMONE AND METABOLIC RESEARCH (2017)
ANGPTL8 (Betatrophin) is Expressed in Visceral Adipose Tissue and Relates to Human Hepatic Steatosis in Two Independent Clinical Collectives
Christian von Loeffelholz et al.
HORMONE AND METABOLIC RESEARCH (2017)
Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions
Timon E. Adolph et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients
Jung Hee Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis
Zhongwei Zhou et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Association between Nicotinamide Phosphoribosyltransferase and de novo Lipogenesis in Nonalcoholic Fatty Liver Disease
Bahareh Amirkalali et al.
MEDICAL PRINCIPLES AND PRACTICE (2017)
Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
Ruth C. R. Meex et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients
Rafael Bergesch D'Incao et al.
OBESITY SURGERY (2017)
HEPATIC CHEMERIN MRNA IN MORBIDLY OBESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
Maciej Kajor et al.
POLISH JOURNAL OF PATHOLOGY (2017)
Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
Yifan Sun et al.
ONCOTARGET (2017)
Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study
Yaru Li et al.
PLOS ONE (2017)
Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease
Thomas Ebert et al.
ENDOCRINE (2017)
Apelin protects against liver X receptor-mediated steatosis through AMPK and PPARα in human and mouse hepatocytes
Jin Huang et al.
CELLULAR SIGNALLING (2017)
Angiopoietin-like protein 8: An attractive biomarker for the evaluation of subjects with insulin resistance and related disorders
Su Wang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
George Cholankeril et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
Alessandro Mantovani et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
A dipose tissue, obesity and non-alcoholic fatty liver disease
Stergios A. Polyzos et al.
MINERVA ENDOCRINOLOGICA (2017)
Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection
I-Ting Tsai et al.
CYTOKINE (2017)
Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis
Stergios A. Polyzos et al.
DIABETOLOGIA (2016)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial
Kenneth Cusi et al.
ANNALS OF INTERNAL MEDICINE (2016)
Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation
Jing Shen et al.
ANTICANCER RESEARCH (2016)
Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma
Mohammed M. H. Al-Gayyar et al.
BIOLOGICAL CHEMISTRY (2016)
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer
A. Blythe Ryerson et al.
CANCER (2016)
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition
Shigeki Nakagawa et al.
CANCER CELL (2016)
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
Sahil Mittal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Regulation of lipid metabolism by angiopoietin-like proteins
Wieneke Dijk et al.
CURRENT OPINION IN LIPIDOLOGY (2016)
Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma
Hsin-An Chen et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Retinol-Binding Protein 4 Induces Hepatic Mitochondrial Dysfunction and Promotes Hepatic Steatosis
Yan Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Fetuin A is a Predictor of Liver Fat in Preoperative Patients with Nonalcoholic Fatty Liver Disease
C. von Loeffelholz et al.
JOURNAL OF INVESTIGATIVE SURGERY (2016)
Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
Luca Valenti et al.
LIVER INTERNATIONAL (2016)
The Obesity Epidemic - Understanding the Disease and the Treatment
Caroline M. Apovian
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Reduced Expression of Chemerin in Visceral Adipose Tissue Associates with Hepatic Steatosis in Patients with Obesity
Marlies Bekaert et al.
Obesity (2016)
Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population
Zhitong Wu et al.
ONCOTARGET (2016)
Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma
Yan Li et al.
ONCOTARGET (2016)
The Effects of Serum ANGPTL8/betatrophin on the Risk of Developing the Metabolic Syndrome-A Prospective Study
Haoyu Wang et al.
SCIENTIFIC REPORTS (2016)
Regulation of Hepatic Stellate Cells and Fibrogenesis by Fibroblast Growth Factors
Justin D. Schumacher et al.
BIOMED RESEARCH INTERNATIONAL (2016)
SERUM LEPTIN LEVENS AND HEPATOCELLULAR CARCINOMA: REVIEW ARTICLE
Luiza Vitelo Andrighetto et al.
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY (2016)
Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis
Diptadip Dattaroy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism
Ruth C. Meex et al.
CELL METABOLISM (2015)
Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma
Mazen Noureddin et al.
CLINICS IN LIVER DISEASE (2015)
Hepatokines: unlocking the multi-organ network in metabolic diseases
Alison Iroz et al.
DIABETOLOGIA (2015)
ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma
Lin Gao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC
Luca Vigano et al.
JOURNAL OF HEPATOLOGY (2015)
Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis
Fernando Bril et al.
JOURNAL OF HEPATOLOGY (2015)
Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease A Strobe-Compliant Article
Ya Huang et al.
MEDICINE (2015)
Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort
Julia Kaulsch et al.
SCIENTIFIC REPORTS (2015)
The Fibroblast Growth Factor signaling pathway
David M. Ornitz et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2015)
Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects
Motoya Sato et al.
LIVER INTERNATIONAL (2015)
Serum Adiponectin Is Associated with Worsened Overall Survival in a Prospective Cohort of Hepatocellular Carcinoma Patients
Abby B. Siegel et al.
ONCOLOGY (2015)
Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis
Mei Yang et al.
PLOS ONE (2015)
Fibroblast Growth Factor Receptor 4 Polymorphism Is Associated with Liver Cirrhosis in Hepatocarcinoma
Ming-Jen Sheu et al.
PLOS ONE (2015)
Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways
Ryan B. Perumpail et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Inflammatory and Metabolic Biomarkers and Risk of Liver and Biliary Tract Cancer
Krasimira Aleksandrova et al.
HEPATOLOGY (2014)
Impact of Serum Chemerin Levels on Liver Functional Reserves and Platelet Counts in Patients with Hepatocellular Carcinoma
Kenji Imai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Toll-like Receptor Status in Obesity and Metabolic Syndrome: A Translational Perspective
Ishwarlal Jialal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma
Kevin Tak-Pan Ng et al.
MOLECULAR CANCER (2014)
Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients
Alexander Wree et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Adiponectin Receptor Expression Predicts Favorable Prognosis in Cases of Hepatocellular Carcinoma
Eun Shin et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH)
Sonia M. Najjar et al.
SEMINARS IN IMMUNOPATHOLOGY (2014)
Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family
Zhiyao Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: Role of autophagy
Rui Guo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress
Chaofeng Yang et al.
BMC GASTROENTEROLOGY (2013)
Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome
F. Cauchy et al.
BRITISH JOURNAL OF SURGERY (2013)
An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice
William L. Holland et al.
CELL METABOLISM (2013)
Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients
Alisan Kahraman et al.
CLINICAL SCIENCE (2013)
Expression of Fibroblast Growth Factor 19 Is Associated with Recurrence and Poor Prognosis of Hepatocellular Carcinoma
Jiyeon Hyeon et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
DIABETES AND CANCER-AN AACE/ACE CONSENSUS STATEMENT
Yehuda Handelsman et al.
ENDOCRINE PRACTICE (2013)
Identification of Chemerin as a Novel FXR Target Gene Down-Regulated in the Progression of Nonalcoholic Steatohepatitis
Yujie Deng et al.
ENDOCRINOLOGY (2013)
Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease
S. Doecke et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver
Sabrina Krautbauer et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis
Lars P. Bechmann et al.
HEPATOLOGY (2013)
The role of Hepassocin in the development of non-alcoholic fatty liver disease
Hung-Tsung Wu et al.
JOURNAL OF HEPATOLOGY (2013)
The role of hepatokines in metabolism
Norbert Stefan et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Retinol Binding Protein-4 Circulating Levels Were Higher in Nonalcoholic Fatty Liver Disease Vs. Histologically Normal Liver from Morbidly Obese Women
Ximena Terra et al.
OBESITY (2013)
Targeted Deletion of Fibrinogen Like Protein 1 Reveals a Novel Role in Energy Substrate Utilization
Valeriy Demchev et al.
PLOS ONE (2013)
Immunological functions of leptin and adiponectin
Fortunata Carbone et al.
BIOCHIMIE (2012)
Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
Seiki Miura et al.
BMC CANCER (2012)
Obesity-related hepatocellular carcinoma: roles of risk factors altered in obesity
Chuan Shen et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
Fibrosis-dependent mechanisms of hepatocarcinogenesis
David Y. Zhang et al.
HEPATOLOGY (2012)
The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients
N. A. H. Sadik et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2012)
Visfatin Levels in Nonalcoholic Fatty Liver Disease
Erdem Akbal et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2012)
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Durba Pal et al.
NATURE MEDICINE (2012)
The Independent Association Between 25-Hydroxyvitamin D and Adiponectin and Its Relation With BMI in Two Large Cohorts: The NHS and the HPFS
Anand Vaidya et al.
OBESITY (2012)
Possible Role of Visfatin in Hepatoma Progression and the Effects of Branched-Chain Amino Acids on Visfatin-Induced Proliferation in Human Hepatoma Cells
Soranobu Ninomiya et al.
CANCER PREVENTION RESEARCH (2011)
Obesity Affects the Liver - The Link between Adipocytes and Hepatocytes
Alexander Wree et al.
DIGESTION (2011)
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis
Salvatore Petta et al.
DIGESTIVE AND LIVER DISEASE (2011)
RBP4: a controversial adipokine
Primoz Kotnik et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Changing trends in malignant transformation of hepatocellular adenoma
Olivier Farges et al.
GUT (2011)
Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
Judith Ertle et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Increased levels of serum leptin are a risk factor for the recurrence of stage I/II hepatocellular carcinoma after curative treatment
Naoki Watanabe et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2011)
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Haitao Wen et al.
NATURE IMMUNOLOGY (2011)
Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease
Yusuf Yilmaz et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Adiponectin in insulin resistance: lessons from translational research
Florencia Ziemke et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Suppression of Liver Tumor Growth and Metastasis by Adiponectin in Nude Mice through Inhibition of Tumor Angiogenesis and Downregulation of Rho Kinase/IFN-Inducible Protein 10/Matrix Metalloproteinase 9 Signaling
Kwan Man et al.
CLINICAL CANCER RESEARCH (2010)
The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease
Stergios A. Polyzos et al.
DIABETES OBESITY & METABOLISM (2010)
Serum Chemerin Levels Vary with Time of Day and Are Modified by Obesity and Tumor Necrosis Factor-α
Sebastian D. Parlee et al.
ENDOCRINOLOGY (2010)
Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and Inhibits Hepatocellular Carcinoma
Neeraj K. Saxena et al.
GASTROENTEROLOGY (2010)
Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure
Chang-Yan Li et al.
GUT (2010)
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Brad Q. Starley et al.
HEPATOLOGY (2010)
Adiponectin Antagonizes the Oncogenic Actions of Leptin in Hepatocellular Carcinogenesis
Dipali Sharma et al.
HEPATOLOGY (2010)
Metabolic Regulator βKlotho Interacts with Fibroblast Growth Factor Receptor 4 (FGFR4) to Induce Apoptosis and Inhibit Tumor Cell Proliferation
Yongde Luo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mapping of the Fibroblast Growth Factors in Human White Adipose Tissue
Niklas Mejhert et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Chemerin Correlates with Markers for Fatty Liver in Morbidly Obese Patients and Strongly Decreases after Weight Loss Induced by Bariatric Surgery
Henrike Sell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
Huating Li et al.
JOURNAL OF HEPATOLOGY (2010)
Plasma apelin levels in subjects with nonalcoholic fatty liver disease
Cemal Nuri Ercin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Serum chemerin and vaspin in non-alcoholic fatty liver disease
Michal Kukla et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis
Matthias J. Bahr et al.
CLINICAL ENDOCRINOLOGY (2009)
ORIGINAL ARTICLES-LIVER, PANCREAS, AND BILIARY TRACT
Valerio Nobili et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
The role of resistin as a regulator of inflammation: Implications for various human pathologies
Maria Filkova et al.
CLINICAL IMMUNOLOGY (2009)
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Jing Xu et al.
DIABETES (2009)
Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin
Bee K. Tan et al.
DIABETES (2009)
Influence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease
R. Aller et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Hepatocellular Carcinomas in Patients With Metabolic Syndrome Often Develop Without Significant Liver Fibrosis: A Pathological Analysis
Valerie Paradis et al.
HEPATOLOGY (2009)
Adipocyte Fatty Acid Binding Protein Levels Relate to Inflammation and Fibrosis in Nonalcoholic Fatty Liver Disease
Kerry-Lee Milner et al.
HEPATOLOGY (2009)
Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease
Maria Schina et al.
HEPATOLOGY RESEARCH (2009)
Adiponectin Levels and Risk of Type 2 Diabetes A Systematic Review and Meta-analysis
Shanshan Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Specific Expression and Regulation of Hepassocin in the Liver and Down-regulation of the Correlation of HNF1α with Decreased Levels of Hepassocin in Human Hepatocellular Carcinoma
Hai-Tao Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population
Kiymet Bozaoglu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Serum Retinol-binding Protein 4 Levels in Patients With Nonalcoholic Fatty Liver Disease
Naim Alkhouri et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis
Takeharu Asano et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis
Thomas Ebert et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Triglyceride Levels and Not Adipokine Concentrations Are Closely Related to Severity of Nonalcoholic Fatty Liver Disease in an Obesity Surgery Cohort
Sangeeta R. Kashyap et al.
OBESITY (2009)
Pattern of Expression of Adiponectin Receptors in Human Liver and its Relation to Nonalcoholic Steatohepatitis
M. Nannipieri et al.
OBESITY SURGERY (2009)
Leptin enhances cholangiocarcinoma cell growth
Giammarco Fava et al.
CANCER RESEARCH (2008)
Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease
J. A. Seo et al.
CLINICAL ENDOCRINOLOGY (2008)
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Xinmei Zhang et al.
DIABETES (2008)
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Tamer Coskun et al.
ENDOCRINOLOGY (2008)
High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase
Masayuki Adachi et al.
HEPATOLOGY (2008)
Adipocytokines and liver disease
Yoshihiro Kamada et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Chemerin is a novel adipokine associated with obesity and metabolic syndrome
Kiymet Bozaoglu et al.
ENDOCRINOLOGY (2007)
Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor Isoforms determines metabolic activity of FGF19 and FGF21
Hiroshi Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic hispanics and african-americans
Anthony J. G. Hanley et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4
Eray Yagmur et al.
DIABETES CARE (2007)
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members
Regina Goetz et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells
Neeraj K. Saxena et al.
CANCER RESEARCH (2007)
Visfatin, an adipocytokine with proinflammatory and immunomodulating properties
Alexander R. Moschen et al.
JOURNAL OF IMMUNOLOGY (2007)
Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation
Naomi Hosogai et al.
DIABETES (2007)
TNFα up-regulates apelin expression in human and mouse adipose tissue
Daniele Daviaud et al.
FASEB JOURNAL (2006)
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects
Timothy E. Graham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity
S Mandard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway
N Silswal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Q Yang et al.
NATURE (2005)
Resistin, an adipokine with potent proinflammatory properties
M Bokarewa et al.
JOURNAL OF IMMUNOLOGY (2005)
High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo
F Tacke et al.
JOURNAL OF HEPATOLOGY (2005)
Apelin, a newly identified adipokine up-regulated by insulin and obesity
J Boucher et al.
ENDOCRINOLOGY (2005)
Angiopoietin-related growth factor antagonizes obesity and insulin resistance
Y Oike et al.
NATURE MEDICINE (2005)
Mechanisms underlying differential responses to FGF signaling
L Dailey et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
JA Davila et al.
GUT (2005)
LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma
J Yan et al.
ONCOGENE (2004)
Adiponectin as a biomarker of the metabolic syndrome
M Ryo et al.
CIRCULATION JOURNAL (2004)
Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization method
XY Dong et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Serum resistin (FIZZ3) protein is increased in obese humans
M Degawa-Yamauchi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Resistin and type 2 diabetes: Regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes
PG McTernan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Leptin in hepatic fibrosis:: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice
NK Saxena et al.
HEPATOLOGY (2002)
分享论文
